DFDA

Treatments

969 treatments. Sorted by trials, participants, effectiveness, and safety. Radical concept: compare the evidence before swallowing things.

Yellow Fever Vaccine (Live Attenuated)

Used for 1 condition

14 trials · 100M participants

Vaccinations (Influenza & Pneumococcal)

Used for 2 conditions

1,300 trials · 10.5M participants

Measles, Mumps, and Rubella (MMR) Vaccine

Used for 1 condition

69 trials · 10M participants

Metformin

Used for 5 conditions

2,898 trials · 7.5M participants

Levothyroxine

Used for 2 conditions

143 trials · 6M participants

Surgical Resection

Used for 4 conditions

872 trials · 5.1M participants

Combined Oral Contraceptives (COCs)

Used for 2 conditions

51 trials · 5.1M participants

Hepatitis A Vaccine (Post-exposure prophylaxis)

Used for 1 condition

200 trials · 5M participants

Smoking Cessation

Used for 1 condition

2,000 trials · 5M participants

Lifestyle Modifications (Diet, Exercise, Smoking Cessation)

Used for 1 condition

2 trials · 5M participants

Laparoscopic Cholecystectomy

Used for 1 condition

139 trials · 5M participants

Isoniazid, Rifampicin, Pyrazinamide, Ethambutol (HRZE) followed by Isoniazid, Rifampicin (HR) Regimen

Used for 1 condition

5,000 trials · 5M participants

Oral Ferrous Sulfate

Used for 1 condition

137 trials · 5M participants

Acetaminophen (for fever and pain)

Used for 1 condition

1,500 trials · 5M participants

Lisinopril

Used for 8 conditions

2,942 trials · 3.3M participants

Lifestyle Modifications (Diet & Exercise)

Used for 2 conditions

10 trials · 3M participants

Prednisone

Used for 7 conditions

107 trials · 2.3M participants

Albendazole

Used for 3 conditions

78 trials · 2M participants

Insulin Therapy (Basal-Bolus Regimen)

Used for 1 condition

21 trials · 2M participants

Surgery (Wide Local Excision/Glossectomy)

Used for 1 condition

5,000 trials · 2M participants

Azithromycin

Used for 9 conditions

340 trials · 1.8M participants

Mebendazole

Used for 2 conditions

1,220 trials · 1.8M participants

Ivermectin

Used for 1 condition

4 trials · 1.5M participants

Hydrochlorothiazide (Thiazide Diuretic)

Used for 1 condition

1 trials · 1.5M participants

Radiation Therapy (External Beam)

Used for 1 condition

5 trials · 1.5M participants

Lisinopril (ACE Inhibitor)

Used for 3 conditions

802 trials · 1.4M participants

Doxycycline

Used for 6 conditions

361 trials · 1.3M participants

Omeprazole (Proton Pump Inhibitor)

Used for 3 conditions

5,071 trials · 1.2M participants

Statins (e.g., Atorvastatin)

Used for 3 conditions

351 trials · 1.1M participants

Oxygen Therapy

Used for 3 conditions

1,601 trials · 1.1M participants

Acetaminophen (Paracetamol)

Used for 2 conditions

73 trials · 1.1M participants

Benzathine Penicillin G

Used for 2 conditions

29 trials · 1.1M participants

Bronchodilators (e.g., Salbutamol, Tiotropium)

Used for 2 conditions

1,150 trials · 1M participants

Symptomatic Medications (e.g., Antiemetics, Analgesics)

Used for 1 condition

500 trials · 1M participants

Supportive Care

Used for 2 conditions

5,000 trials · 1M participants

NSAIDs (e.g., Diclofenac, Naproxen)

Used for 1 condition

1,000 trials · 1M participants

Pyrantel Pamoate

Used for 1 condition

1 trials · 1M participants

Atorvastatin

Used for 3 conditions

723 trials · 1M participants

Daily Mechanical Plaque Removal (Brushing & Flossing)

Used for 1 condition

1 trials · 1M participants

Folic Acid Supplementation (Prevention)

Used for 1 condition

1,000 trials · 1M participants

Radical Inguinal Orchiectomy

Used for 1 condition

1 trials · 1M participants

Tetanus Toxoid Vaccine (e.g., Tdap, Td)

Used for 1 condition

1,000 trials · 1M participants

Red Blood Cell Transfusions

Used for 1 condition

24 trials · 1M participants

Thyroidectomy

Used for 1 condition

195 trials · 1M participants

Hysterectomy (Surgical Resection)

Used for 1 condition

41 trials · 1M participants

Hysterectomy

Used for 1 condition

56 trials · 1M participants

Supportive Care (for active infection)

Used for 1 condition

1,000 trials · 1M participants

Metoprolol

Used for 4 conditions

162 trials · 800K participants

Amlodipine (Dihydropyridine CCB)

Used for 1 condition

2 trials · 800K participants

Aspirin

Used for 2 conditions

540 trials · 700K participants

Atorvastatin (Statin Therapy)

Used for 2 conditions

25 trials · 700K participants

Praziquantel

Used for 2 conditions

43 trials · 508K participants

Methylphenidate (Ritalin, Concerta)

Used for 1 condition

341 trials · 500K participants

Laparoscopic Appendectomy

Used for 1 condition

141 trials · 500K participants

Open Appendectomy

Used for 1 condition

56 trials · 500K participants

Intensive Insulin Therapy

Used for 1 condition

500 trials · 500K participants

Lifestyle Modifications (Sodium Restriction, Exercise)

Used for 1 condition

300 trials · 500K participants

ACE Inhibitors / ARBs (e.g., Lisinopril)

Used for 1 condition

800 trials · 500K participants

Oral Rehydration Therapy

Used for 1 condition

1 trials · 500K participants

Insulin (Basal)

Used for 1 condition

392 trials · 500K participants

Oral Rehydration Solution (ORS)

Used for 1 condition

2 trials · 500K participants

Chlorthalidone

Used for 1 condition

89 trials · 500K participants

Valsartan (ARB)

Used for 1 condition

2 trials · 500K participants

Chloroquine Phosphate

Used for 1 condition

131 trials · 500K participants

Estrogen-Progestogen Therapy (EPT)

Used for 1 condition

1 trials · 500K participants

Therapeutic Lifestyle Changes (Diet and Exercise)

Used for 1 condition

38 trials · 500K participants

Mitral Valve Repair (Surgical)

Used for 1 condition

1,500 trials · 500K participants

Primary Cleft Lip Repair (Cheiloplasty)

Used for 1 condition

5,000 trials · 500K participants

Micronutrient Supplementation

Used for 1 condition

3 trials · 500K participants

D2 Gastrectomy (Surgery)

Used for 1 condition

95 trials · 500K participants

Levothyroxine (TSH Suppression Therapy)

Used for 1 condition

6 trials · 500K participants

Amphetamines (Mixed Amphetamine Salts, Lisdexamfetamine)

Used for 1 condition

7 trials · 400K participants

Radiation Therapy

Used for 5 conditions

2,724 trials · 400K participants

Beta-blockers (e.g., Metoprolol)

Used for 1 condition

600 trials · 400K participants

Glimepiride (Sulfonylurea)

Used for 1 condition

61 trials · 400K participants

Amlodipine

Used for 1 condition

540 trials · 400K participants

Metoprolol Succinate (Beta-blocker)

Used for 1 condition

1,000 trials · 400K participants

Mitral Valve Replacement (Surgical)

Used for 1 condition

1,200 trials · 400K participants

Primary Cleft Palate Repair (Palatoplasty)

Used for 1 condition

4,000 trials · 400K participants

Liver Transplantation

Used for 5 conditions

6,055 trials · 368K participants

Valsartan

Used for 1 condition

258 trials · 350K participants

Immunoglobulin (Post-exposure prophylaxis)

Used for 1 condition

100 trials · 300K participants

Intranasal Corticosteroids (INCS)

Used for 1 condition

6 trials · 300K participants

ACE Inhibitors (e.g., Lisinopril)

Used for 2 conditions

1,000 trials · 300K participants

Aspirin (Low-dose)

Used for 1 condition

66 trials · 300K participants

Endoscopic Retrograde Cholangiopancreatography (ERCP)

Used for 1 condition

33 trials · 300K participants

H. pylori Eradication Therapy (e.g., Amoxicillin + Clarithromycin + Omeprazole)

Used for 1 condition

3,000 trials · 300K participants

Amoxicillin

Used for 2 conditions

19 trials · 300K participants

Oral NSAIDs (e.g., Ibuprofen, Naproxen)

Used for 1 condition

1,500 trials · 300K participants

Levodopa (Carbidopa/Levodopa)

Used for 1 condition

171 trials · 300K participants

Leuprolide (Androgen Deprivation Therapy - ADT)

Used for 1 condition

79 trials · 300K participants

Dapagliflozin

Used for 4 conditions

131 trials · 295K participants

Ceftriaxone

Used for 7 conditions

361 trials · 288K participants

Topical Corticosteroids (e.g., Clobetasol Propionate 0.05%)

Used for 1 condition

1,000 trials · 250K participants

Clopidogrel

Used for 2 conditions

600 trials · 250K participants

Ibuprofen

Used for 2 conditions

14 trials · 225K participants

Hematopoietic Stem Cell Transplantation (HSCT)

Used for 2 conditions

164 trials · 220K participants

Levofloxacin

Used for 2 conditions

360 trials · 215K participants

Topical Retinoids (e.g., Adapalene, Tretinoin)

Used for 1 condition

2,000 trials · 200K participants

Tamoxifen (Hormone Therapy)

Used for 1 condition

251 trials · 200K participants

Smoking Cessation (Behavioral Therapy + Pharmacotherapy)

Used for 1 condition

500 trials · 200K participants

Standard 6-Month Regimen (Isoniazid, Rifampicin, Pyrazinamide, Ethambutol then Isoniazid, Rifampicin for active TB)

Used for 1 condition

500 trials · 200K participants

Esophagectomy (Surgery)

Used for 1 condition

195 trials · 200K participants

Latanoprost

Used for 1 condition

251 trials · 200K participants

Open Tension-Free Mesh Repair (Lichtenstein Technique)

Used for 1 condition

1,000 trials · 200K participants

Long-term Antiplatelet Therapy (Aspirin)

Used for 1 condition

5 trials · 200K participants

Lisinopril (Blood Pressure Lowering)

Used for 1 condition

200 trials · 200K participants

Sumatriptan

Used for 1 condition

103 trials · 200K participants

Metoprolol (Beta-blocker)

Used for 1 condition

1 trials · 200K participants

Surgical Aortic Valve Replacement (SAVR)

Used for 1 condition

800 trials · 200K participants

Medical Management / Watchful Waiting

Used for 1 condition

500 trials · 200K participants

Methadone

Used for 1 condition

124 trials · 200K participants

Orthodontic Treatment

Used for 1 condition

2,000 trials · 200K participants

Pneumococcal Conjugate Vaccine (PCV)

Used for 1 condition

2 trials · 200K participants

Ready-to-Use Therapeutic Food (RUTF)

Used for 1 condition

2 trials · 200K participants

Continuous Positive Airway Pressure (CPAP)

Used for 1 condition

647 trials · 200K participants

Platinum-based Chemotherapy (Cisplatin + Pemetrexed)

Used for 1 condition

1,000 trials · 200K participants

Methotrexate

Used for 4 conditions

823 trials · 184K participants

Timolol

Used for 1 condition

266 trials · 180K participants

Antiplatelet Therapy (e.g., Aspirin)

Used for 2 conditions

1,300 trials · 180K participants

Acyclovir

Used for 5 conditions

113 trials · 175K participants

Pulmonary Rehabilitation

Used for 4 conditions

1,267 trials · 165K participants

Adalimumab

Used for 5 conditions

620 trials · 161K participants

Cognitive Behavioral Therapy (CBT)

Used for 8 conditions

2,916 trials · 153K participants

Doxorubicin + Cyclophosphamide + Paclitaxel (AC-T Chemotherapy Regimen)

Used for 1 condition

21 trials · 150K participants

Semaglutide

Used for 2 conditions

28 trials · 150K participants

Angiotensin Receptor Blockers (e.g., Losartan)

Used for 1 condition

400 trials · 150K participants

Bronchodilators (e.g., LAMA/LABA)

Used for 1 condition

400 trials · 150K participants

Surgical Ventricular Septal Defect (VSD) Repair

Used for 1 condition

4 trials · 150K participants

Artificial Tears

Used for 1 condition

235 trials · 150K participants

Ureteroscopy (URS)

Used for 2 conditions

42 trials · 150K participants

Cisplatin (with Radiation Therapy)

Used for 1 condition

61 trials · 150K participants

Artemether-Lumefantrine

Used for 1 condition

223 trials · 150K participants

Mohs Micrographic Surgery

Used for 1 condition

4 trials · 150K participants

Diuretics (e.g., Furosemide) for Symptom Management

Used for 1 condition

800 trials · 150K participants

Speech Therapy

Used for 1 condition

1,500 trials · 150K participants

Nitrofurantoin

Used for 2 conditions

51 trials · 150K participants

Sertraline (SSRI)

Used for 3 conditions

332 trials · 149K participants

Dexamethasone

Used for 3 conditions

125 trials · 140K participants

Concurrent Chemoradiation (Cisplatin-based)

Used for 2 conditions

71 trials · 130K participants

Erythromycin

Used for 3 conditions

93 trials · 127K participants

Propranolol

Used for 2 conditions

32 trials · 125K participants

Excisional Hemorrhoidectomy

Used for 1 condition

28 trials · 120K participants

Percutaneous Nephrolithotomy (PCNL)

Used for 2 conditions

160 trials · 120K participants

Transcatheter Aortic Valve Replacement (TAVR)

Used for 1 condition

550 trials · 120K participants

Fluticasone/Salmeterol

Used for 2 conditions

194 trials · 115K participants

Etanercept

Used for 2 conditions

249 trials · 110K participants

Venlafaxine (SNRI)

Used for 2 conditions

22 trials · 110K participants

External Beam Radiation Therapy (EBRT)

Used for 4 conditions

144 trials · 110K participants

Infliximab

Used for 5 conditions

584 trials · 101K participants

Radiofrequency Ablation (RFA)

Used for 5 conditions

374 trials · 101K participants

Multi-agent Chemotherapy (e.g., Hyper-CVAD regimen)

Used for 1 condition

1 trials · 100K participants

Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)

Used for 1 condition

100 trials · 100K participants

Fluticasone propionate

Used for 1 condition

394 trials · 100K participants

Transurethral Resection of the Prostate (TURP)

Used for 1 condition

86 trials · 100K participants

Radical Hysterectomy

Used for 1 condition

99 trials · 100K participants

Radiation Therapy (EBRT + Brachytherapy)

Used for 1 condition

101 trials · 100K participants

Surgical Tetralogy of Fallot (TOF) Repair

Used for 1 condition

10 trials · 100K participants

LAMA Monotherapy (e.g., Tiotropium)

Used for 1 condition

100 trials · 100K participants

Semaglutide (GLP-1 Receptor Agonist)

Used for 1 condition

27 trials · 100K participants

Zinc Supplementation

Used for 1 condition

1 trials · 100K participants

Surgical Repair of Congenital Heart Defects

Used for 1 condition

1 trials · 100K participants

Special Education Services

Used for 1 condition

300 trials · 100K participants

Isoniazid (INH) Monotherapy (9 months for Latent TB Infection)

Used for 1 condition

300 trials · 100K participants

Laparoscopic Excision Surgery

Used for 1 condition

42 trials · 100K participants

Antibiotics (e.g., Piperacillin-tazobactam)

Used for 1 condition

1 trials · 100K participants

Famotidine (H2 Receptor Blocker)

Used for 2 conditions

501 trials · 100K participants

Professional Dental Cleaning (Prophylaxis)

Used for 1 condition

4 trials · 100K participants

Radioactive Iodine (I-131) Therapy

Used for 1 condition

1 trials · 100K participants

Total Laryngectomy (Surgery)

Used for 1 condition

14 trials · 100K participants

Amoxicillin/Clavulanate

Used for 1 condition

1 trials · 100K participants

Dihydroartemisinin-Piperaquine

Used for 1 condition

143 trials · 100K participants

Surgery (Limb-Sparing Resection/Amputation)

Used for 1 condition

1,000 trials · 100K participants

Ventriculoperitoneal (VP) Shunt Placement

Used for 1 condition

500 trials · 100K participants

Surgical Excision

Used for 1 condition

7 trials · 100K participants

Alendronate

Used for 1 condition

154 trials · 100K participants

Surgical Correction (e.g., Lysis of Adhesions, Resection)

Used for 1 condition

500 trials · 100K participants

H. pylori Eradication (Quadruple Therapy)

Used for 1 condition

14 trials · 100K participants

Famotidine (H2-Receptor Antagonist)

Used for 1 condition

4 trials · 100K participants

Dietary Counseling and Education

Used for 1 condition

1 trials · 100K participants

Antibiotics (e.g., Amoxicillin, Azithromycin)

Used for 1 condition

500 trials · 100K participants

Weight Loss (Lifestyle Modification)

Used for 1 condition

18 trials · 100K participants

Extracorporeal Shockwave Lithotripsy (ESWL)

Used for 1 condition

48 trials · 100K participants

Varicella Vaccine (Chickenpox Vaccine)

Used for 1 condition

188 trials · 100K participants

Blood Pressure Control (e.g., Lisinopril)

Used for 1 condition

500 trials · 100K participants

Lifestyle Management (Exercise & Diet)

Used for 1 condition

500 trials · 100K participants

Valacyclovir

Used for 3 conditions

69 trials · 95K participants

Lamotrigine

Used for 2 conditions

415 trials · 85K participants

Cephalexin

Used for 2 conditions

19 trials · 85K participants

Topiramate

Used for 4 conditions

70 trials · 83K participants

Furosemide

Used for 2 conditions

101 trials · 80K participants

Oral H1 Antihistamines (2nd Generation)

Used for 1 condition

1 trials · 80K participants

Tiotropium

Used for 2 conditions

64 trials · 80K participants

Pembrolizumab

Used for 4 conditions

1,183 trials · 80K participants

Catheter-based Atrial Septal Defect (ASD) Closure

Used for 1 condition

1 trials · 80K participants

Empagliflozin (SGLT2 Inhibitor)

Used for 1 condition

69 trials · 80K participants

Sitagliptin (DPP-4 Inhibitor)

Used for 1 condition

91 trials · 80K participants

Probiotics (Lactobacillus rhamnosus GG / Saccharomyces boulardii)

Used for 1 condition

500 trials · 80K participants

Methimazole

Used for 1 condition

31 trials · 80K participants

Carbamazepine

Used for 1 condition

600 trials · 80K participants

Mesalamine

Used for 2 conditions

304 trials · 80K participants

Bariatric Surgery (e.g., Gastric Bypass)

Used for 1 condition

1 trials · 80K participants

Alveolar Bone Grafting (ABG)

Used for 1 condition

800 trials · 80K participants

Weight Management (Diet & Exercise)

Used for 1 condition

16 trials · 80K participants

Levetiracetam

Used for 2 conditions

184 trials · 78K participants

Isotretinoin

Used for 1 condition

45 trials · 75K participants

Bevacizumab

Used for 3 conditions

505 trials · 75K participants

Trastuzumab (HER2-targeted therapy)

Used for 1 condition

89 trials · 75K participants

Pembrolizumab (Immunotherapy)

Used for 3 conditions

81 trials · 75K participants

SGLT2 Inhibitors (e.g., Dapagliflozin)

Used for 2 conditions

55 trials · 75K participants

Famciclovir

Used for 3 conditions

17 trials · 75K participants

ABVD (Doxorubicin, Bleomycin, Vinblastine, Dacarbazine)

Used for 1 condition

48 trials · 75K participants

Valproate

Used for 1 condition

2 trials · 75K participants

Laparoscopic Transabdominal Preperitoneal (TAPP) or Totally Extraperitoneal (TEP) Mesh Repair

Used for 1 condition

1 trials · 75K participants

Endovascular Revascularization (Angioplasty/Stenting)

Used for 1 condition

3 trials · 75K participants

Warfarin

Used for 1 condition

2 trials · 75K participants

Apixaban

Used for 1 condition

177 trials · 70K participants

PCSK9 Inhibitors (e.g., Evolocumab)

Used for 1 condition

50 trials · 70K participants

Beta-blockers (e.g., Carvedilol)

Used for 1 condition

1 trials · 70K participants

Brimonidine

Used for 1 condition

105 trials · 70K participants

Apixaban (Anticoagulation for AFib-related stroke)

Used for 1 condition

10 trials · 70K participants

Cetuximab (Targeted Therapy)

Used for 2 conditions

5 trials · 70K participants

Transarterial Chemoembolization (TACE)

Used for 4 conditions

450 trials · 70K participants

Amoxicillin-Clavulanate

Used for 2 conditions

20 trials · 65K participants

Acetaminophen

Used for 1 condition

2 trials · 65K participants

Oral Contraceptives (combined estrogen-progestin)

Used for 1 condition

350 trials · 60K participants

LABA/ICS Combination (e.g., Fluticasone/Salmeterol)

Used for 1 condition

1 trials · 60K participants

Sucralfate

Used for 2 conditions

500 trials · 60K participants

Dorzolamide

Used for 1 condition

79 trials · 60K participants

Open Repair for Umbilical or Epigastric Hernia (Mesh or Suture)

Used for 1 condition

400 trials · 60K participants

Ranibizumab

Used for 1 condition

381 trials · 60K participants

Psychosocial Support & Counseling (e.g., CBT, Contingency Management)

Used for 1 condition

400 trials · 60K participants

Secondary Rhinoplasty / Orthognathic Surgery

Used for 1 condition

600 trials · 60K participants

Ready-to-Use Supplementary Food (RUSF)

Used for 1 condition

1 trials · 60K participants

Hydroxyurea

Used for 2 conditions

183 trials · 60K participants

Naproxen

Used for 1 condition

1 trials · 60K participants

Trimethoprim/Sulfamethoxazole

Used for 1 condition

43 trials · 60K participants

Trimethoprim-sulfamethoxazole (TMP-SMX)

Used for 1 condition

1 trials · 60K participants

Rubber Band Ligation

Used for 1 condition

14 trials · 55K participants

Topical Calcineurin Inhibitors (e.g., Tacrolimus Ointment)

Used for 2 conditions

370 trials · 54K participants

Amitriptyline

Used for 5 conditions

53 trials · 54K participants

Lithium

Used for 2 conditions

174 trials · 51K participants

Mirtazapine

Used for 2 conditions

75 trials · 51K participants

Donepezil

Used for 3 conditions

221 trials · 51K participants

Benzoyl Peroxide

Used for 1 condition

179 trials · 50K participants

Liver Transplant

Used for 1 condition

1,000 trials · 50K participants

Cytarabine + Daunorubicin ("7+3" Induction Chemotherapy)

Used for 1 condition

22 trials · 50K participants

Hydrocortisone

Used for 1 condition

18 trials · 50K participants

Carvedilol

Used for 1 condition

150 trials · 50K participants

Allergen Immunotherapy (AIT)

Used for 1 condition

19 trials · 50K participants

Albuterol

Used for 1 condition

475 trials · 50K participants

Catheter Ablation

Used for 1 condition

869 trials · 50K participants

Tamsulosin (Alpha-blocker)

Used for 1 condition

19 trials · 50K participants

Carpal Tunnel Release Surgery

Used for 1 condition

85 trials · 50K participants

Liraglutide

Used for 1 condition

100 trials · 50K participants

Dapagliflozin (SGLT2 Inhibitor)

Used for 1 condition

50 trials · 50K participants

FOLFOX (Fluorouracil, Leucovorin, Oxaliplatin)

Used for 1 condition

56 trials · 50K participants

Arterial Switch Operation (ASO) for Transposition of Great Arteries (TGA)

Used for 1 condition

1 trials · 50K participants

Surgical Coarctation of Aorta Repair

Used for 1 condition

4 trials · 50K participants

Ponseti Method for Clubfoot

Used for 1 condition

8 trials · 50K participants

LAMA/LABA Combination (e.g., Umeclidinium/Vilanterol)

Used for 1 condition

50 trials · 50K participants

Clinical Monitoring and Early Intervention

Used for 1 condition

100 trials · 50K participants

Continuous Glucose Monitoring (CGM)

Used for 1 condition

417 trials · 50K participants

Loperamide

Used for 1 condition

6 trials · 50K participants

Oral Antibiotics (e.g., Ciprofloxacin + Metronidazole)

Used for 1 condition

1 trials · 50K participants

Early Intervention Programs (Comprehensive Developmental Therapies)

Used for 1 condition

500 trials · 50K participants

Narrowband UVB Phototherapy

Used for 2 conditions

19 trials · 50K participants

Tiotropium (LAMA)

Used for 1 condition

1 trials · 50K participants

Systemic Chemotherapy (e.g., FOLFOX/CAPOX)

Used for 1 condition

3,000 trials · 50K participants

Ursodeoxycholic Acid (UDCA)

Used for 1 condition

8 trials · 50K participants

Radiation Therapy (Adjuvant/Palliative)

Used for 1 condition

500 trials · 50K participants

Vitamin D (for deficiency)

Used for 1 condition

2 trials · 50K participants

ACE Inhibitors (Lisinopril) / ARBs (Valsartan)

Used for 1 condition

100 trials · 50K participants

Recombinant Factor VIII

Used for 1 condition

351 trials · 50K participants

Spironolactone (MRA)

Used for 1 condition

500 trials · 50K participants

Propylthiouracil (PTU)

Used for 1 condition

2 trials · 50K participants

Surgical Septal Myectomy

Used for 1 condition

13 trials · 50K participants

Beta-blockers (e.g., Metoprolol, Propranolol)

Used for 1 condition

500 trials · 50K participants

Iodine Supplementation (for iodine deficiency)

Used for 1 condition

300 trials · 50K participants

Oseltamivir

Used for 1 condition

4 trials · 50K participants

Hydroxychloroquine

Used for 1 condition

38 trials · 50K participants

Aflibercept

Used for 1 condition

280 trials · 50K participants

Atovaquone-Proguanil

Used for 1 condition

36 trials · 50K participants

Multi-agent Chemotherapy (e.g., Methotrexate, Doxorubicin, Cisplatin, Ifosfamide)

Used for 1 condition

500 trials · 50K participants

Vancomycin

Used for 1 condition

4 trials · 50K participants

Postnatal Myelomeningocele Repair

Used for 1 condition

4 trials · 50K participants

Diuretic Therapy (e.g., Furosemide)

Used for 1 condition

200 trials · 50K participants

Buprenorphine/Naloxone

Used for 1 condition

115 trials · 50K participants

Exercise and Physical Therapy

Used for 1 condition

430 trials · 50K participants

Intra-articular Corticosteroid Injections (IACI)

Used for 1 condition

2 trials · 50K participants

Tympanostomy Tube Insertion

Used for 1 condition

60 trials · 50K participants

Carboplatin + Paclitaxel

Used for 1 condition

347 trials · 50K participants

Intravenous Fluid Resuscitation (e.g., Lactated Ringer's)

Used for 1 condition

500 trials · 50K participants

Dopamine Agonists (e.g., Pramipexole, Ropinirole)

Used for 1 condition

300 trials · 50K participants

Docetaxel

Used for 1 condition

509 trials · 50K participants

Therapeutic Milk (F-75, F-100)

Used for 1 condition

1 trials · 50K participants

Oxamniquine

Used for 1 condition

100 trials · 50K participants

Oral Appliance Therapy (OAT)

Used for 1 condition

2 trials · 50K participants

BEP Chemotherapy (Bleomycin, Etoposide, Cisplatin)

Used for 1 condition

8 trials · 50K participants

Retroperitoneal Lymph Node Dissection (RPLND)

Used for 1 condition

7 trials · 50K participants

Radioactive Iodine-131 (I-131) Therapy

Used for 1 condition

14 trials · 50K participants

Carboplatin + Etoposide

Used for 1 condition

500 trials · 50K participants

Myomectomy

Used for 1 condition

101 trials · 50K participants

Advanced Wound Dressings (e.g., Hydrocolloids, Foams, Alginates)

Used for 1 condition

400 trials · 45K participants

Gabapentin

Used for 4 conditions

96 trials · 45K participants

Azathioprine

Used for 4 conditions

151 trials · 45K participants

Fosfomycin

Used for 2 conditions

186 trials · 45K participants

Tamsulosin (Medical Expulsive Therapy)

Used for 1 condition

5 trials · 45K participants

Pregabalin

Used for 4 conditions

225 trials · 41K participants

Ciprofloxacin

Used for 3 conditions

301 trials · 41K participants

Oral Antibiotics (e.g., Doxycycline)

Used for 1 condition

400 trials · 40K participants

Lung Transplantation

Used for 2 conditions

302 trials · 40K participants

Amiodarone

Used for 1 condition

150 trials · 40K participants

Quetiapine

Used for 1 condition

120 trials · 40K participants

Valproate (Divalproex)

Used for 1 condition

120 trials · 40K participants

Trimethoprim-Sulfamethoxazole

Used for 1 condition

10 trials · 40K participants

Clindamycin

Used for 2 conditions

28 trials · 40K participants

FOLFIRI (Fluorouracil, Leucovorin, Irinotecan)

Used for 1 condition

49 trials · 40K participants

Ustekinumab

Used for 4 conditions

304 trials · 40K participants

Azithromycin (for bacterial diarrhea)

Used for 1 condition

200 trials · 40K participants

Fluticasone/Salmeterol (ICS/LABA combination)

Used for 1 condition

80 trials · 40K participants

Sclerotherapy

Used for 1 condition

14 trials · 40K participants

Calcium Channel Blockers (e.g., Verapamil, Diltiazem)

Used for 1 condition

400 trials · 40K participants

Laparoscopic Ventral/Incisional Hernia Repair (with Mesh)

Used for 1 condition

250 trials · 40K participants

Primaquine

Used for 1 condition

120 trials · 40K participants

Watchful Waiting / Cardiovascular Risk Factor Modification

Used for 1 condition

100 trials · 40K participants

Topical NSAIDs (e.g., Diclofenac gel)

Used for 1 condition

200 trials · 40K participants

Opioid Analgesics (e.g., Hydromorphone)

Used for 1 condition

400 trials · 40K participants

Abiraterone acetate (with Prednisone)

Used for 1 condition

194 trials · 40K participants

Cefalexin

Used for 1 condition

300 trials · 40K participants

Zoster Vaccine, Recombinant, Adjuvanted (Shingrix)

Used for 1 condition

9 trials · 40K participants

Venous Stripping and Ligation

Used for 1 condition

13 trials · 40K participants

Rituximab

Used for 4 conditions

248 trials · 37K participants

Tofacitinib

Used for 3 conditions

182 trials · 36K participants

Temozolomide + Radiation Therapy

Used for 1 condition

141 trials · 35K participants

Pressure Redistribution Surfaces (e.g., Alternating Pressure Mattress)

Used for 1 condition

300 trials · 35K participants

Electroconvulsive Therapy (ECT)

Used for 1 condition

170 trials · 35K participants

Duloxetine

Used for 2 conditions

75 trials · 35K participants

Zolpidem

Used for 1 condition

80 trials · 35K participants

Enzalutamide

Used for 1 condition

380 trials · 35K participants

Spironolactone

Used for 3 conditions

13 trials · 33K participants

Levothyroxine + Liothyronine (Combination Therapy)

Used for 2 conditions

58 trials · 33K participants

Cyclophosphamide

Used for 2 conditions

151 trials · 30K participants

Atomoxetine

Used for 1 condition

136 trials · 30K participants

Leukotriene Receptor Antagonists (LTRAs)

Used for 1 condition

200 trials · 30K participants

Duloxetine (SNRI)

Used for 2 conditions

6 trials · 30K participants

Montelukast

Used for 1 condition

178 trials · 30K participants

Sotalol

Used for 1 condition

40 trials · 30K participants

Finasteride (5-alpha-reductase inhibitor)

Used for 1 condition

13 trials · 30K participants

Radical Cystectomy

Used for 1 condition

270 trials · 30K participants

Corticosteroids (short-term oral)

Used for 1 condition

150 trials · 30K participants

Capecitabine (oral)

Used for 1 condition

45 trials · 30K participants

Fontan Procedure

Used for 1 condition

58 trials · 30K participants

Pavlik Harness for Developmental Dysplasia of the Hip (DDH)

Used for 1 condition

200 trials · 30K participants

Racecadotril

Used for 1 condition

150 trials · 30K participants

Concurrent Chemoradiation

Used for 1 condition

196 trials · 30K participants

Antacids (e.g., Aluminum Hydroxide/Magnesium Hydroxide)

Used for 1 condition

300 trials · 30K participants

Lifestyle Modifications

Used for 1 condition

5 trials · 30K participants

Chlorhexidine Gluconate Mouthrinse (0.12%)

Used for 1 condition

4 trials · 30K participants

Selective Laser Trabeculoplasty (SLT)

Used for 1 condition

63 trials · 30K participants

Beta-blockers (Carvedilol, Metoprolol succinate)

Used for 1 condition

16 trials · 30K participants

Recombinant Factor IX

Used for 1 condition

61 trials · 30K participants

Total Thyroidectomy

Used for 1 condition

12 trials · 30K participants

Isosorbide Mononitrate

Used for 1 condition

21 trials · 30K participants

Extracorporeal Shock Wave Lithotripsy (ESWL)

Used for 1 condition

43 trials · 30K participants

Surgical Revascularization (Bypass Surgery)

Used for 1 condition

9 trials · 30K participants

AREDS2 Formula Supplements

Used for 1 condition

1 trials · 30K participants

Quinine Sulfate + Doxycycline

Used for 1 condition

1 trials · 30K participants

Low-dose Aspirin

Used for 1 condition

100 trials · 30K participants

Vitamin A Supplementation

Used for 1 condition

1 trials · 30K participants

Concurrent Chemoradiotherapy (Cisplatin-based)

Used for 1 condition

12 trials · 30K participants

5-Fluorouracil (topical)

Used for 1 condition

2 trials · 30K participants

Endoscopic Retrograde Cholangiopancreatography (ERCP) with Sphincterotomy and Stone Removal

Used for 1 condition

7 trials · 30K participants

Conservative Management (NPO, NG decompression, IV fluids)

Used for 1 condition

300 trials · 30K participants

Abatacept

Used for 1 condition

139 trials · 30K participants

Aqueous Crystalline Penicillin G

Used for 1 condition

300 trials · 30K participants

Active Surveillance (for Stage I)

Used for 1 condition

6 trials · 30K participants

Osimertinib

Used for 1 condition

300 trials · 30K participants

Orchiopexy for Cryptorchidism

Used for 1 condition

3 trials · 30K participants

Carboplatin + Paclitaxel (Adjuvant/Palliative Chemotherapy)

Used for 1 condition

200 trials · 30K participants

Uterine Artery Embolization (UAE)

Used for 1 condition

13 trials · 30K participants

Endovenous Laser Ablation (EVLA)

Used for 1 condition

19 trials · 30K participants

Anticoagulation (e.g., Rivaroxaban)

Used for 1 condition

150 trials · 30K participants

Secukinumab

Used for 2 conditions

164 trials · 28K participants

Nivolumab

Used for 3 conditions

193 trials · 27K participants

Olanzapine

Used for 3 conditions

108 trials · 27K participants

Finerenone

Used for 2 conditions

22 trials · 26K participants

Vedolizumab

Used for 3 conditions

367 trials · 26K participants

Mycophenolate Mofetil

Used for 2 conditions

181 trials · 25K participants

Cognitive Behavioral Therapy (CBT) for ADHD

Used for 1 condition

63 trials · 25K participants

Indacaterol/Glycopyrronium

Used for 1 condition

100 trials · 25K participants

Topical Nasal Corticosteroids (e.g., Fluticasone Propionate)

Used for 1 condition

200 trials · 25K participants

Bevacizumab (added to chemotherapy)

Used for 1 condition

2 trials · 25K participants

ARNI (Sacubitril/Valsartan)

Used for 1 condition

1 trials · 25K participants

Surgical Resection (Partial Hepatectomy)

Used for 1 condition

500 trials · 25K participants

Shouldice Repair (Open Tissue Repair)

Used for 1 condition

2 trials · 25K participants

Cognitive Behavioral Therapy for Insomnia (CBT-I)

Used for 1 condition

311 trials · 25K participants

Alteplase (Intravenous Thrombolysis)

Used for 1 condition

108 trials · 25K participants

Tamsulosin

Used for 1 condition

23 trials · 25K participants

Bortezomib

Used for 1 condition

591 trials · 25K participants

Photodynamic Therapy (PDT)

Used for 1 condition

6 trials · 25K participants

Pancreatic Enzyme Replacement Therapy (PERT)

Used for 1 condition

4 trials · 25K participants

Opioid-Sparing Analgesia (e.g., Multimodal Pain Management)

Used for 1 condition

200 trials · 25K participants

Clomiphene Citrate (for Ovulation Induction)

Used for 1 condition

45 trials · 25K participants

FOLFOX Chemotherapy

Used for 1 condition

65 trials · 25K participants

Deferasirox

Used for 1 condition

49 trials · 25K participants

Durvalumab

Used for 1 condition

300 trials · 25K participants

Pseudoephedrine

Used for 1 condition

24 trials · 25K participants

Ureteral Reimplantation for Vesicoureteral Reflux (VUR)

Used for 1 condition

400 trials · 25K participants

Sclerotherapy (Foam/Liquid)

Used for 1 condition

4 trials · 25K participants

Rivastigmine

Used for 2 conditions

58 trials · 24K participants

Ixekizumab

Used for 2 conditions

56 trials · 23K participants

Nirmatrelvir/Ritonavir (Paxlovid)

Used for 2 conditions

54 trials · 23K participants

Prednisone (Corticosteroid)

Used for 2 conditions

201 trials · 22K participants

Ceftriaxone + Azithromycin (Dual Therapy)

Used for 1 condition

160 trials · 22K participants

Magnesium Sulfate

Used for 2 conditions

21 trials · 22K participants

Denosumab

Used for 1 condition

151 trials · 22K participants

Memantine

Used for 3 conditions

81 trials · 22K participants

Cefixime

Used for 2 conditions

12 trials · 21K participants

Cyclosporine

Used for 2 conditions

30 trials · 21K participants

Betahistine

Used for 2 conditions

13 trials · 21K participants

Contingency Management

Used for 2 conditions

18 trials · 20K participants

Fludrocortisone

Used for 1 condition

200 trials · 20K participants

Motivational Enhancement Therapy (MET)

Used for 1 condition

27 trials · 20K participants

Flecainide

Used for 1 condition

48 trials · 20K participants

Combination Therapy (Tamsulosin + Finasteride)

Used for 1 condition

7 trials · 20K participants

Aripiprazole

Used for 1 condition

81 trials · 20K participants

BCG (Bacillus Calmette-Guérin) Intravesical Therapy

Used for 1 condition

24 trials · 20K participants

Corticosteroid Injection (e.g., Methylprednisolone)

Used for 1 condition

200 trials · 20K participants

Imatinib

Used for 1 condition

306 trials · 20K participants

Cetuximab (added to chemotherapy, RAS Wild-Type)

Used for 1 condition

150 trials · 20K participants

Surgical Correction for Clubfoot

Used for 1 condition

1 trials · 20K participants

Triple Therapy (LAMA/LABA/ICS, e.g., Fluticasone furoate/Umeclidinium/Vilanterol)

Used for 1 condition

10 trials · 20K participants

Remdesivir

Used for 1 condition

123 trials · 20K participants

Debridement (Sharp, Enzymatic, Autolytic)

Used for 1 condition

200 trials · 20K participants

Intravenous Fluid Therapy (Crystalloids)

Used for 1 condition

50 trials · 20K participants

High-Fiber Diet

Used for 1 condition

3 trials · 20K participants

Speech-Language Therapy

Used for 1 condition

5 trials · 20K participants

Rifampicin (RIF) Monotherapy (4 months for Latent TB Infection)

Used for 1 condition

25 trials · 20K participants

Laparoscopic Salpingectomy

Used for 1 condition

8 trials · 20K participants

Umeclidinium/Vilanterol (LABA/LAMA combination)

Used for 1 condition

50 trials · 20K participants

Gemcitabine + Cisplatin

Used for 1 condition

41 trials · 20K participants

Misoprostol

Used for 1 condition

200 trials · 20K participants

Nissen Fundoplication (Laparoscopic)

Used for 1 condition

44 trials · 20K participants

Essential Oil Mouthrinse (e.g., Listerine Antiseptic)

Used for 1 condition

200 trials · 20K participants

Spectinomycin

Used for 1 condition

100 trials · 20K participants

4-month Rifapentine-Moxifloxacin-Isoniazid-Pyrazinamide (RPT-M-H-Z) Regimen

Used for 1 condition

50 trials · 20K participants

Clofazimine (as component of XDR-TB regimen)

Used for 1 condition

100 trials · 20K participants

Intravenous Iron Sucrose

Used for 1 condition

46 trials · 20K participants

Dual Antiplatelet Therapy (Aspirin + Clopidogrel)

Used for 1 condition

29 trials · 20K participants

Radiofrequency Ablation (RFA) / Microwave Ablation (MWA)

Used for 1 condition

300 trials · 20K participants

Erenumab

Used for 1 condition

64 trials · 20K participants

Conventional Longer MDR-TB Regimen (Injectable-containing)

Used for 1 condition

100 trials · 20K participants

Lenalidomide

Used for 1 condition

599 trials · 20K participants

Transcatheter Edge-to-Edge Repair (TEER)

Used for 1 condition

100 trials · 20K participants

Zoledronic Acid

Used for 1 condition

112 trials · 20K participants

Watchful Waiting / Symptomatic Treatment (Analgesics/Antipyretics)

Used for 1 condition

100 trials · 20K participants

Early Enteral Nutrition (via nasogastric or nasojejunal tube)

Used for 1 condition

250 trials · 20K participants

Deep Brain Stimulation (DBS)

Used for 1 condition

336 trials · 20K participants

Endovascular Coiling

Used for 1 condition

17 trials · 20K participants

Surgical Clipping

Used for 1 condition

19 trials · 20K participants

Radiation Therapy (for Seminoma)

Used for 1 condition

4 trials · 20K participants

Hypospadias Repair

Used for 1 condition

39 trials · 20K participants

Oral Naltrexone

Used for 1 condition

14 trials · 18K participants

Negative Pressure Wound Therapy (NPWT)

Used for 1 condition

19 trials · 18K participants

Cyclosporine ophthalmic emulsion

Used for 1 condition

95 trials · 18K participants

Desiccated Thyroid Extract (DTE)

Used for 2 conditions

110 trials · 18K participants

Intensity-Modulated Radiation Therapy (IMRT) alone (for early stage)

Used for 1 condition

1 trials · 18K participants

Venlafaxine

Used for 1 condition

5 trials · 18K participants

Aspirin + Acetaminophen + Caffeine (Combination)

Used for 1 condition

150 trials · 18K participants

Pyeloplasty for Ureteropelvic Junction (UPJ) Obstruction

Used for 1 condition

350 trials · 18K participants

Lenvatinib

Used for 5 conditions

84 trials · 18K participants

Atezolizumab + Bevacizumab

Used for 4 conditions

77 trials · 17K participants

Ceftriaxone + Doxycycline (Dual Therapy)

Used for 1 condition

110 trials · 16K participants

Eszopiclone

Used for 1 condition

48 trials · 16K participants

Sorafenib

Used for 4 conditions

53 trials · 16K participants

Mycophenolate Mofetil (MMF)

Used for 2 conditions

115 trials · 15K participants

Corticosteroids (e.g., Prednisone)

Used for 2 conditions

125 trials · 15K participants

Acamprosate

Used for 1 condition

12 trials · 15K participants

Combination Intranasal Corticosteroid + Antihistamine

Used for 1 condition

4 trials · 15K participants

Galantamine

Used for 1 condition

58 trials · 15K participants

Alprazolam (Benzodiazepine)

Used for 1 condition

35 trials · 15K participants

Radiation Therapy (External Beam Radiation Therapy - EBRT)

Used for 1 condition

19 trials · 15K participants

Palbociclib (CDK4/6 Inhibitor)

Used for 1 condition

74 trials · 15K participants

Night Splinting / Wrist Bracing

Used for 1 condition

2 trials · 15K participants

Budesonide/Glycopyrronium/Formoterol

Used for 1 condition

15 trials · 15K participants

Dasatinib

Used for 1 condition

142 trials · 15K participants

Dupilumab

Used for 2 conditions

118 trials · 15K participants

Roflumilast (PDE4 Inhibitor)

Used for 1 condition

4 trials · 15K participants

Tocilizumab

Used for 1 condition

86 trials · 15K participants

Transsphenoidal Surgery

Used for 1 condition

1 trials · 15K participants

Surgical Shunt (e.g., VP Shunt)

Used for 1 condition

100 trials · 15K participants

Nutritional Support (High Protein, Vitamin C, Zinc)

Used for 1 condition

180 trials · 15K participants

SGLT2 Inhibitor (Dapagliflozin)

Used for 1 condition

14 trials · 15K participants

Mineralocorticoid Receptor Antagonists (e.g., Spironolactone)

Used for 1 condition

1 trials · 15K participants

Penicillin G (or Procaine Penicillin)

Used for 1 condition

50 trials · 15K participants

Elective Colectomy

Used for 1 condition

5 trials · 15K participants

Physical Therapy

Used for 1 condition

55 trials · 15K participants

Occupational Therapy

Used for 1 condition

1 trials · 15K participants

Laparoscopic Salpingostomy

Used for 1 condition

5 trials · 15K participants

Immunotherapy (e.g., Pembrolizumab, Nivolumab)

Used for 1 condition

300 trials · 15K participants

Aerobic Exercise

Used for 1 condition

74 trials · 15K participants

Pelvic Floor Muscle Training (PFMT)

Used for 1 condition

2 trials · 15K participants

NSAIDs (e.g., Indomethacin, Naproxen)

Used for 1 condition

150 trials · 15K participants

Sacubitril/Valsartan

Used for 1 condition

132 trials · 15K participants

Mineralocorticoid Receptor Antagonists (Spironolactone)

Used for 1 condition

10 trials · 15K participants

Doppler-guided Hemorrhoidal Artery Ligation (DG-HAL)

Used for 1 condition

1 trials · 15K participants

Cisplatin-based Chemotherapy

Used for 1 condition

1 trials · 15K participants

BEACOPP (Bleomycin, Etoposide, Doxorubicin, Cyclophosphamide, Vincristine, Procarbazine, Prednisone)

Used for 1 condition

12 trials · 15K participants

Intravenous Ferric Carboxymaltose

Used for 1 condition

100 trials · 15K participants

Supervised Exercise Therapy (SET)

Used for 1 condition

150 trials · 15K participants

Surgery (Pleurectomy/Decortication or Extrapleural Pneumonectomy) + Adjuvant Therapy

Used for 1 condition

1 trials · 15K participants

Rimegepant

Used for 1 condition

45 trials · 15K participants

Daratumumab

Used for 1 condition

293 trials · 15K participants

Induction Chemotherapy + Concurrent Chemoradiotherapy (Cisplatin-based)

Used for 1 condition

8 trials · 15K participants

Raloxifene

Used for 1 condition

35 trials · 15K participants

MAO-B Inhibitors (e.g., Rasagiline, Selegiline)

Used for 1 condition

70 trials · 15K participants

NSAIDs (Ibuprofen/Naproxen)

Used for 1 condition

2 trials · 15K participants

Chronic Blood Transfusion Therapy

Used for 1 condition

16 trials · 15K participants

Alectinib

Used for 1 condition

200 trials · 15K participants

Leuprolide (GnRH Agonist)

Used for 1 condition

4 trials · 15K participants

Compression Stockings

Used for 1 condition

46 trials · 15K participants

Nivolumab + Ipilimumab

Used for 3 conditions

139 trials · 14K participants

Saline Nasal Irrigation

Used for 2 conditions

40 trials · 14K participants

Autologous Stem Cell Transplant (ASCT)

Used for 2 conditions

122 trials · 12K participants

Nilotinib

Used for 1 condition

141 trials · 12K participants

Omega-3 Fatty Acids (EPA/DHA)

Used for 1 condition

9 trials · 12K participants

Methotrexate (Systemic)

Used for 1 condition

2 trials · 12K participants

Fiber Supplements (e.g., Psyllium)

Used for 1 condition

120 trials · 12K participants

Ethambutol (as part of an optimized background regimen for MDR-TB)

Used for 1 condition

60 trials · 12K participants

Cilostazol

Used for 1 condition

4 trials · 12K participants

Pemetrexed + Cisplatin (or Carboplatin)

Used for 1 condition

21 trials · 12K participants

Romosozumab

Used for 1 condition

30 trials · 12K participants

Letrozole (for Ovulation Induction)

Used for 1 condition

28 trials · 12K participants

Radium-223 dichloride

Used for 1 condition

76 trials · 12K participants

Guselkumab

Used for 1 condition

61 trials · 12K participants

Sildenafil

Used for 1 condition

125 trials · 12K participants

Dextromethorphan

Used for 1 condition

6 trials · 12K participants

Epley maneuver

Used for 1 condition

25 trials · 12K participants

Cefixime + Azithromycin (Dual Therapy, Oral Alternative)

Used for 1 condition

85 trials · 11K participants

Upadacitinib

Used for 2 conditions

41 trials · 11K participants

Carbidopa/Levodopa

Used for 1 condition

55 trials · 11K participants

Sofosbuvir/Velpatasvir

Used for 1 condition

1 trials · 10K participants

Dasatinib (for Ph+ ALL)

Used for 1 condition

35 trials · 10K participants

Melarsoprol

Used for 1 condition

1 trials · 10K participants

Alcohol Abstinence

Used for 1 condition

0 trials · 10K participants

Intranasal Antihistamines (e.g., Azelastine)

Used for 1 condition

100 trials · 10K participants

Buspirone

Used for 1 condition

16 trials · 10K participants

Omalizumab

Used for 1 condition

112 trials · 10K participants

Lurasidone

Used for 1 condition

31 trials · 10K participants

Gemcitabine + Cisplatin Chemotherapy

Used for 1 condition

112 trials · 10K participants

Nutritional Supplementation (e.g., Iron, Vitamin D, Folate, B12)

Used for 1 condition

50 trials · 10K participants

Roflumilast

Used for 1 condition

5 trials · 10K participants

Fludarabine + Cyclophosphamide + Rituximab (FCR)

Used for 1 condition

35 trials · 10K participants

Endoscopic Sinus Surgery (ESS)

Used for 1 condition

12 trials · 10K participants

Prostaglandin E1 (Alprostadil) Infusion

Used for 1 condition

1 trials · 10K participants

Surgical Reduction and Osteotomy for DDH

Used for 1 condition

150 trials · 10K participants

Spinal Fusion for Congenital Scoliosis

Used for 1 condition

100 trials · 10K participants

Baricitinib

Used for 1 condition

30 trials · 10K participants

Molnupiravir

Used for 1 condition

22 trials · 10K participants

Esketamine (Nasal Spray)

Used for 1 condition

20 trials · 10K participants

Automated Insulin Delivery (AID) Systems

Used for 1 condition

45 trials · 10K participants

Esophageal Atresia Repair (Primary Anastomosis)

Used for 1 condition

1 trials · 10K participants

Hirschsprung's Disease Pull-through Procedure

Used for 1 condition

7 trials · 10K participants

Conservative Management (Bowel Rest/Clear Liquid Diet)

Used for 1 condition

50 trials · 10K participants

Thyroid Hormone Replacement (Levothyroxine) for Hypothyroidism

Used for 1 condition

100 trials · 10K participants

3HP Regimen (Isoniazid + Rifapentine weekly for 3 months for Latent TB Infection)

Used for 1 condition

15 trials · 10K participants

Oxygen Therapy (long-term)

Used for 1 condition

2 trials · 10K participants

Penicillin G

Used for 1 condition

6 trials · 10K participants

Vancomycin + Gentamicin

Used for 1 condition

2 trials · 10K participants

Dienogest

Used for 1 condition

37 trials · 10K participants

NSAIDs (Ibuprofen, Naproxen)

Used for 1 condition

20 trials · 10K participants

Folic Acid Supplementation

Used for 1 condition

50 trials · 10K participants

Durvalumab + Gemcitabine/Cisplatin

Used for 1 condition

5 trials · 10K participants

Vaginal Pessaries

Used for 1 condition

7 trials · 10K participants

Native Tissue Repair (Colporrhaphy)

Used for 1 condition

1 trials · 10K participants

Vaginal Estrogen (Topical)

Used for 1 condition

100 trials · 10K participants

Stannous Fluoride (SnF2) Toothpaste/Mouthrinse

Used for 1 condition

100 trials · 10K participants

Febuxostat

Used for 1 condition

65 trials · 10K participants

Allopurinol

Used for 1 condition

71 trials · 10K participants

Colchicine

Used for 2 conditions

46 trials · 10K participants

Loop Diuretics (Furosemide)

Used for 1 condition

44 trials · 10K participants

Doxorubicin (as part of multi-agent chemotherapy)

Used for 1 condition

200 trials · 10K participants

Linezolid (as component of XDR-TB regimen)

Used for 1 condition

50 trials · 10K participants

Linezolid (as part of an optimized background regimen for MDR-TB)

Used for 1 condition

50 trials · 10K participants

Cryotherapy (Liquid Nitrogen)

Used for 1 condition

11 trials · 10K participants

Imiquimod

Used for 1 condition

11 trials · 10K participants

Alcohol Septal Ablation

Used for 1 condition

8 trials · 10K participants

Ramelteon

Used for 1 condition

49 trials · 10K participants

Trimethoprim-Sulfamethoxazole (TMP-SMX)

Used for 1 condition

100 trials · 10K participants

Intravenous Iron Dextran (High Molecular Weight)

Used for 1 condition

50 trials · 10K participants

Linaclotide

Used for 1 condition

26 trials · 10K participants

Faricimab

Used for 1 condition

26 trials · 10K participants

Amphotericin B (Lipid Formulations)

Used for 1 condition

100 trials · 10K participants

Ubrogepant

Used for 1 condition

21 trials · 10K participants

Bedaquiline-based Regimen (longer course)

Used for 1 condition

50 trials · 10K participants

Carfilzomib

Used for 1 condition

219 trials · 10K participants

Autologous Stem Cell Transplantation (ASCT)

Used for 1 condition

144 trials · 10K participants

Naltrexone (Extended-Release Injectable)

Used for 1 condition

16 trials · 10K participants

Pancreaticoduodenectomy (Whipple Procedure) + Adjuvant Chemotherapy

Used for 1 condition

12 trials · 10K participants

Gemcitabine monotherapy

Used for 1 condition

65 trials · 10K participants

Alvimopan

Used for 1 condition

25 trials · 10K participants

COMT Inhibitors (e.g., Entacapone)

Used for 1 condition

50 trials · 10K participants

Fluoxetine (SSRI)

Used for 1 condition

50 trials · 10K participants

Apremilast

Used for 1 condition

94 trials · 10K participants

Systemic Chemotherapy (e.g., VEC regimen)

Used for 1 condition

150 trials · 10K participants

Metronidazole (topical)

Used for 1 condition

9 trials · 10K participants

Metrifonate

Used for 1 condition

50 trials · 10K participants

Uvulopalatopharyngoplasty (UPPP)

Used for 1 condition

8 trials · 10K participants

Trastuzumab + Chemotherapy (for HER2-positive)

Used for 1 condition

30 trials · 10K participants

Procaine Penicillin G + Probenecid

Used for 1 condition

1 trials · 10K participants

Adjuvant Carboplatin (for Stage I Seminoma)

Used for 1 condition

1 trials · 10K participants

Metronidazole

Used for 1 condition

1 trials · 10K participants

Benzodiazepines (e.g., Diazepam, Midazolam)

Used for 1 condition

100 trials · 10K participants

Hearing Aids (for individuals with hearing loss)

Used for 1 condition

1 trials · 10K participants

Thiazide Diuretics (e.g., Hydrochlorothiazide for Prevention)

Used for 1 condition

60 trials · 10K participants

Vaginal Brachytherapy

Used for 1 condition

64 trials · 10K participants

Intramuscular Cobalamin (Cyanocobalamin/Hydroxocobalamin)

Used for 1 condition

9 trials · 10K participants

Oral Cobalamin (Cyanocobalamin/Methylcobalamin)

Used for 1 condition

11 trials · 10K participants

Topical Corticosteroids (e.g., Clobetasol Propionate)

Used for 1 condition

200 trials · 10K participants

Liposomal Doxorubicin

Used for 2 conditions

266 trials · 9,500 participants

Meropenem

Used for 2 conditions

81 trials · 9,500 participants

Loteprednol etabonate ophthalmic suspension (short-term)

Used for 1 condition

60 trials · 9,000 participants

Suvorexant

Used for 1 condition

39 trials · 9,000 participants

Rifaximin

Used for 1 condition

24 trials · 9,000 participants

OnabotulinumtoxinA (Botox)

Used for 1 condition

63 trials · 9,000 participants

Topical Lidocaine (5% patch)

Used for 1 condition

7 trials · 9,000 participants

Tadalafil

Used for 1 condition

44 trials · 9,000 participants

Vestibular Rehabilitation Therapy

Used for 1 condition

91 trials · 8,500 participants

Glecaprevir/Pibrentasvir

Used for 1 condition

3 trials · 8,000 participants

Sofosbuvir/Ledipasvir

Used for 1 condition

3 trials · 8,000 participants

Topiramate (Off-label)

Used for 1 condition

50 trials · 8,000 participants

Physical Therapy / Occupational Therapy

Used for 1 condition

2 trials · 8,000 participants

Ibrutinib

Used for 1 condition

172 trials · 8,000 participants

Bosutinib

Used for 1 condition

43 trials · 8,000 participants

Combination Therapy (Albendazole + Praziquantel + Corticosteroids)

Used for 1 condition

50 trials · 8,000 participants

Surgical Reconstruction (Flaps, Grafts)

Used for 1 condition

80 trials · 8,000 participants

Pramlintide

Used for 1 condition

38 trials · 8,000 participants

Posterior Sagittal Anorectoplasty (PSARP) for Imperforate Anus

Used for 1 condition

1 trials · 8,000 participants

Mesalazine (5-ASA)

Used for 1 condition

6 trials · 8,000 participants

Shorter 4-Month Regimen (High-dose Rifapentine, Isoniazid, Pyrazinamide, Moxifloxacin then High-dose Rifapentine, Isoniazid, Moxifloxacin for active TB)

Used for 1 condition

15 trials · 8,000 participants

Leuprolide

Used for 1 condition

28 trials · 8,000 participants

Laparoscopic/Robotic Sacrocolpopexy

Used for 1 condition

6 trials · 8,000 participants

Extended Half-Life (EHL) Recombinant Factor VIII

Used for 1 condition

2 trials · 8,000 participants

Brentuximab vedotin + AVD (Doxorubicin, Vinblastine, Dacarbazine)

Used for 1 condition

19 trials · 8,000 participants

Selenium Supplementation (adjunctive for Hashimoto's)

Used for 1 condition

50 trials · 8,000 participants

Rapid Reversal of Anticoagulation

Used for 1 condition

3 trials · 8,000 participants

Endovascular Thrombectomy

Used for 1 condition

229 trials · 8,000 participants

Potassium Citrate

Used for 1 condition

23 trials · 8,000 participants

Brolucizumab

Used for 1 condition

50 trials · 8,000 participants

Standardized Shorter MDR-TB Regimen (SSR)

Used for 1 condition

20 trials · 8,000 participants

Docetaxel + Cisplatin + 5-Fluorouracil (TPF Induction Chemotherapy) followed by Concurrent Chemoradiotherapy

Used for 1 condition

3 trials · 8,000 participants

Olaparib

Used for 1 condition

143 trials · 8,000 participants

Early Mobilization/Ambulation

Used for 1 condition

50 trials · 8,000 participants

Amantadine

Used for 1 condition

32 trials · 8,000 participants

Topical Capsaicin (8% patch)

Used for 1 condition

8 trials · 8,000 participants

Clarithromycin

Used for 1 condition

60 trials · 8,000 participants

Combined Oral Contraceptives (Drospirenone/Ethinyl Estradiol)

Used for 1 condition

8 trials · 8,000 participants

Treprostinil (Parenteral/Inhaled)

Used for 1 condition

1 trials · 8,000 participants

Doxycycline (low-dose)

Used for 1 condition

20 trials · 8,000 participants

Tinnitus Retraining Therapy (TRT)

Used for 1 condition

9 trials · 8,000 participants

Endoscopic Valve Ablation for Posterior Urethral Valves (PUV)

Used for 1 condition

250 trials · 8,000 participants

Potassium Citrate (Prevention)

Used for 1 condition

3 trials · 8,000 participants

Pembrolizumab (monotherapy)

Used for 1 condition

36 trials · 8,000 participants

Cyanoacrylate Glue (Venaseal)

Used for 1 condition

50 trials · 8,000 participants

Open Surgical Revascularization

Used for 1 condition

1 trials · 8,000 participants

Cognitive Behavioral Therapy (CBT) adapted for ME/CFS

Used for 1 condition

2 trials · 7,500 participants

Diphtheria Antitoxin (DAT)

Used for 1 condition

1 trials · 7,500 participants

Micronized Purified Flavonoid Fraction (MPFF)

Used for 1 condition

2 trials · 7,500 participants

Surgical Excision / Electrocautery / Laser Ablation

Used for 1 condition

2 trials · 7,500 participants

Doxepin (low-dose)

Used for 1 condition

35 trials · 7,500 participants

Intravenous Ferumoxytol

Used for 1 condition

11 trials · 7,500 participants

Hydrochlorothiazide + Low Sodium Diet

Used for 1 condition

40 trials · 7,500 participants

Paroxetine (low-dose)

Used for 1 condition

4 trials · 7,500 participants

Blinatumomab

Used for 1 condition

127 trials · 7,000 participants

Guanfacine Extended Release

Used for 1 condition

18 trials · 7,000 participants

Disulfiram

Used for 2 conditions

48 trials · 7,000 participants

Acalabrutinib

Used for 1 condition

83 trials · 7,000 participants

Oral Corticosteroids (short course)

Used for 1 condition

1 trials · 7,000 participants

Regorafenib

Used for 1 condition

10 trials · 7,000 participants

Azathioprine / Mercaptopurine

Used for 1 condition

40 trials · 7,000 participants

Nafcillin/Oxacillin

Used for 1 condition

1 trials · 7,000 participants

Clofazimine (as part of an optimized background regimen for MDR-TB)

Used for 1 condition

40 trials · 7,000 participants

Lubiprostone

Used for 1 condition

8 trials · 7,000 participants

Hydrochlorothiazide (HCTZ)

Used for 1 condition

7 trials · 7,000 participants

Stereotactic Body Radiation Therapy (SBRT)

Used for 2 conditions

169 trials · 7,000 participants

Fezolinetant

Used for 1 condition

17 trials · 7,000 participants

Gemcitabine + Cisplatin (for recurrent/metastatic NPC)

Used for 1 condition

21 trials · 7,000 participants

Bosentan

Used for 1 condition

73 trials · 7,000 participants

Daclatasvir + Sofosbuvir

Used for 1 condition

30 trials · 6,000 participants

Gabapentin (Off-label)

Used for 1 condition

40 trials · 6,000 participants

Venetoclax + Obinutuzumab

Used for 1 condition

45 trials · 6,000 participants

Long-term Low-dose Macrolide Antibiotics (e.g., Azithromycin)

Used for 1 condition

35 trials · 6,000 participants

Lifitegrast ophthalmic solution

Used for 1 condition

29 trials · 6,000 participants

Expectant Management

Used for 1 condition

8 trials · 6,000 participants

Selenium Supplementation

Used for 1 condition

4 trials · 6,000 participants

Extended Half-Life (EHL) Recombinant Factor IX

Used for 1 condition

40 trials · 6,000 participants

Trichloroacetic Acid (TCA)

Used for 1 condition

4 trials · 6,000 participants

Lemborexant

Used for 1 condition

21 trials · 6,000 participants

Osmotic Therapy (Mannitol or Hypertonic Saline)

Used for 1 condition

40 trials · 6,000 participants

Eluxadoline

Used for 1 condition

7 trials · 6,000 participants

Vestibular Rehabilitation Therapy (VRT)

Used for 1 condition

1 trials · 6,000 participants

High-dose Moxifloxacin-based Regimen

Used for 1 condition

40 trials · 6,000 participants

Macitentan

Used for 1 condition

20 trials · 6,000 participants

Azelaic Acid (topical)

Used for 1 condition

14 trials · 6,000 participants

Sound Therapy (Masking, Notched Sound, Habituation)

Used for 1 condition

120 trials · 6,000 participants

Endovascular Revascularization (Angioplasty & Stenting)

Used for 1 condition

80 trials · 6,000 participants

Sodium Stibogluconate (SSG)

Used for 1 condition

5 trials · 6,000 participants

Sumatriptan (subcutaneous)

Used for 1 condition

55 trials · 5,500 participants

Teriparatide

Used for 1 condition

131 trials · 5,500 participants

Meclizine

Used for 1 condition

2 trials · 5,500 participants

Liposomal Amphotericin B

Used for 1 condition

18 trials · 5,500 participants

Zinc (lozenges/syrup)

Used for 1 condition

22 trials · 5,200 participants

Plasma Exchange

Used for 1 condition

1 trials · 5,000 participants

Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir

Used for 1 condition

1 trials · 5,000 participants

Inotuzumab Ozogamicin

Used for 1 condition

50 trials · 5,000 participants

Gemtuzumab Ozogamicin (GO) + Chemotherapy

Used for 1 condition

21 trials · 5,000 participants

Dehydroepiandrosterone (DHEA)

Used for 1 condition

2 trials · 5,000 participants

Pentamidine

Used for 1 condition

1 trials · 5,000 participants

Family-Based Treatment (FBT)

Used for 1 condition

27 trials · 5,000 participants

Antibiotic Therapy (for uncomplicated appendicitis)

Used for 1 condition

13 trials · 5,000 participants

UroLift System (Prostatic Urethral Lift)

Used for 1 condition

5 trials · 5,000 participants

Pembrolizumab (Keytruda)

Used for 1 condition

117 trials · 5,000 participants

Tumor Treating Fields (Optune)

Used for 1 condition

7 trials · 5,000 participants

Lomustine

Used for 1 condition

40 trials · 5,000 participants

Rituximab with Hyper-CVAD/MA

Used for 1 condition

50 trials · 5,000 participants

Oral Corticosteroids (e.g., Prednisone)

Used for 1 condition

50 trials · 5,000 participants

Cisplatin + Paclitaxel + Bevacizumab

Used for 1 condition

35 trials · 5,000 participants

Benznidazole

Used for 1 condition

22 trials · 5,000 participants

Matrix Model

Used for 1 condition

50 trials · 5,000 participants

Pembrolizumab (for MSI-H/dMMR)

Used for 1 condition

50 trials · 5,000 participants

Bisphosphonate Therapy (e.g., Pamidronate) for Osteogenesis Imperfecta

Used for 1 condition

100 trials · 5,000 participants

Long-Term Oxygen Therapy (LTOT)

Used for 1 condition

21 trials · 5,000 participants

Bilateral Adrenalectomy

Used for 1 condition

1 trials · 5,000 participants

Surgical Excision (Pericystectomy/Cystectomy)

Used for 1 condition

50 trials · 5,000 participants

Ramstedt Pyloromyotomy for Pyloric Stenosis

Used for 1 condition

200 trials · 5,000 participants

Intestinal Resection and Anastomosis for Atresia/Stenosis

Used for 1 condition

200 trials · 5,000 participants

Kasai Portoenterostomy for Biliary Atresia

Used for 1 condition

20 trials · 5,000 participants

Rifaximin (with fiber supplement)

Used for 1 condition

30 trials · 5,000 participants

Alpha-1 Antitrypsin Augmentation Therapy

Used for 1 condition

12 trials · 5,000 participants

Surgical Valve Replacement/Repair

Used for 1 condition

2 trials · 5,000 participants

Elagolix

Used for 1 condition

23 trials · 5,000 participants

Linezolid (as part of regimens)

Used for 1 condition

40 trials · 5,000 participants

Milnacipran

Used for 1 condition

28 trials · 5,000 participants

Gentamicin

Used for 1 condition

3 trials · 5,000 participants

Prednisone (systemic corticosteroids)

Used for 1 condition

50 trials · 5,000 participants

Desmopressin (DDAVP)

Used for 1 condition

8 trials · 5,000 participants

Bedaquiline (as part of a longer oral regimen)

Used for 1 condition

30 trials · 5,000 participants

Podofilox

Used for 1 condition

50 trials · 5,000 participants

Pentosan Polysulfate Sodium

Used for 1 condition

3 trials · 5,000 participants

External Ventricular Drain (EVD) for Hydrocephalus

Used for 1 condition

1 trials · 5,000 participants

Intensive Blood Pressure Lowering

Used for 1 condition

8 trials · 5,000 participants

Low FODMAP Diet

Used for 1 condition

78 trials · 5,000 participants

Belimumab

Used for 1 condition

63 trials · 5,000 participants

High-Dose Chemotherapy with Stem Cell Rescue

Used for 1 condition

50 trials · 5,000 participants

Dabrafenib + Trametinib

Used for 1 condition

18 trials · 5,000 participants

Vemurafenib + Cobimetinib

Used for 1 condition

8 trials · 5,000 participants

Labetalol

Used for 1 condition

200 trials · 5,000 participants

Durvalumab + Tremelimumab

Used for 1 condition

6 trials · 5,000 participants

Delamanid-based Regimen (longer course)

Used for 1 condition

30 trials · 5,000 participants

Ocrelizumab

Used for 1 condition

121 trials · 5,000 participants

Pembrolizumab (for recurrent/metastatic NPC)

Used for 1 condition

3 trials · 5,000 participants

Posterior Fossa Decompression (for symptomatic Chiari II)

Used for 1 condition

50 trials · 5,000 participants

Naltrexone (Oral)

Used for 1 condition

16 trials · 5,000 participants

Niraparib

Used for 1 condition

95 trials · 5,000 participants

Chloramphenicol

Used for 1 condition

20 trials · 5,000 participants

Co-trimoxazole (Trimethoprim-sulfamethoxazole)

Used for 1 condition

25 trials · 5,000 participants

Oral Iron Supplementation (effective if iron deficient)

Used for 1 condition

30 trials · 5,000 participants

Pramipexole

Used for 1 condition

30 trials · 5,000 participants

Ropinirole

Used for 1 condition

25 trials · 5,000 participants

Ivermectin (topical)

Used for 1 condition

6 trials · 5,000 participants

Vascular Laser / IPL Therapy

Used for 1 condition

1 trials · 5,000 participants

Tribendimidine

Used for 1 condition

20 trials · 5,000 participants

Hypoglossal Nerve Stimulation (HGNS)

Used for 1 condition

14 trials · 5,000 participants

Positional Therapy

Used for 1 condition

28 trials · 5,000 participants

FLOT Chemotherapy

Used for 1 condition

46 trials · 5,000 participants

Ramucirumab + Paclitaxel (Second-line)

Used for 1 condition

16 trials · 5,000 participants

Ventricular Drainage (EVD)

Used for 1 condition

16 trials · 5,000 participants

Blood Pressure Control (e.g., Nicardipine IV)

Used for 1 condition

20 trials · 5,000 participants

Tetanus Immune Globulin (TIG)

Used for 1 condition

8 trials · 5,000 participants

Reconstructive Surgery for Bladder Exstrophy

Used for 1 condition

2 trials · 5,000 participants

Lenvatinib + Pembrolizumab

Used for 1 condition

15 trials · 5,000 participants

Medroxyprogesterone Acetate (MPA) / Megestrol Acetate (Hormonal Therapy)

Used for 1 condition

40 trials · 5,000 participants

Broad-spectrum Antibiotics (e.g., Ciprofloxacin + Metronidazole)

Used for 1 condition

50 trials · 5,000 participants

Sublingual Cobalamin (Cyanocobalamin/Methylcobalamin)

Used for 1 condition

2 trials · 5,000 participants

Excimer Laser/Light (308 nm)

Used for 1 condition

6 trials · 5,000 participants

Zanubrutinib

Used for 1 condition

42 trials · 4,500 participants

Intratympanic Gentamicin

Used for 1 condition

2 trials · 4,500 participants

Ponatinib (for Ph+ ALL)

Used for 1 condition

20 trials · 4,000 participants

Enhanced Cognitive Behavioral Therapy (CBT-E)

Used for 1 condition

8 trials · 4,000 participants

Rezum Water Vapor Thermal Therapy

Used for 1 condition

16 trials · 4,000 participants

Rituximab with CODOX-M/IVAC

Used for 1 condition

2 trials · 4,000 participants

Budesonide (controlled ileal release)

Used for 1 condition

30 trials · 4,000 participants

PAIR (Puncture, Aspiration, Injection, Re-aspiration) + Albendazole

Used for 1 condition

40 trials · 4,000 participants

Bedaquiline (as part of longer regimens)

Used for 1 condition

25 trials · 4,000 participants

Delamanid (as part of a longer oral regimen)

Used for 1 condition

25 trials · 4,000 participants

Tricyclic Antidepressants (TCAs)

Used for 1 condition

30 trials · 4,000 participants

Nifedipine (extended-release)

Used for 1 condition

150 trials · 4,000 participants

Fingolimod

Used for 1 condition

101 trials · 4,000 participants

Trimethoprim-sulfamethoxazole

Used for 1 condition

1 trials · 4,000 participants

Calcium Supplementation

Used for 1 condition

1 trials · 4,000 participants

Nimodipine

Used for 1 condition

17 trials · 4,000 participants

Intravenous Immunoglobulin (IVIG)

Used for 3 conditions

22 trials · 3,550 participants

Ribavirin

Used for 1 condition

70 trials · 3,500 participants

Donanemab

Used for 1 condition

10 trials · 3,500 participants

Rituximab with GMALL-B-ALL-BFM

Used for 1 condition

35 trials · 3,500 participants

PAIR (Puncture, Aspiration, Injection, Re-aspiration) Monotherapy

Used for 1 condition

35 trials · 3,500 participants

Punctal Plugs (Silicone or dissolvable)

Used for 1 condition

25 trials · 3,500 participants

Gentamicin + Azithromycin (Dual Therapy for Cephalosporin Allergy)

Used for 1 condition

25 trials · 3,500 participants

Nintedanib

Used for 1 condition

1 trials · 3,500 participants

Intratympanic Dexamethasone

Used for 1 condition

8 trials · 3,500 participants

Cognitive Behavioral Therapy (CBT) for Menopausal Symptoms

Used for 1 condition

12 trials · 3,500 participants

Mindfulness-Based Stress Reduction (MBSR)

Used for 1 condition

5 trials · 3,500 participants

Miltefosine

Used for 1 condition

12 trials · 3,500 participants

Suramin

Used for 1 condition

1 trials · 3,000 participants

Lecanemab

Used for 1 condition

26 trials · 3,000 participants

Dose-adjusted EPOCH with Rituximab (DA-EPOCH-R)

Used for 1 condition

3 trials · 3,000 participants

Yoga / Nerve Gliding Exercises

Used for 1 condition

30 trials · 3,000 participants

Nifurtimox

Used for 1 condition

12 trials · 3,000 participants

Activity Pacing / Energy Management

Used for 1 condition

30 trials · 3,000 participants

Ponatinib

Used for 1 condition

43 trials · 3,000 participants

Methylprednisolone

Used for 1 condition

8 trials · 3,000 participants

Daptomycin

Used for 1 condition

15 trials · 3,000 participants

Trastuzumab (for HER2+ Adenocarcinoma)

Used for 1 condition

15 trials · 3,000 participants

Penciclovir Cream

Used for 1 condition

30 trials · 3,000 participants

Transoral Incisionless Fundoplication (TIF)

Used for 1 condition

15 trials · 3,000 participants

Emicizumab

Used for 1 condition

48 trials · 3,000 participants

Vincristine + 5-Fluorouracil (5-FU)

Used for 1 condition

5 trials · 3,000 participants

Nivolumab (PD-1 inhibitor)

Used for 1 condition

14 trials · 3,000 participants

Sacral Neuromodulation (SNM)

Used for 1 condition

1 trials · 3,000 participants

Open Craniotomy for Hematoma Evacuation

Used for 1 condition

5 trials · 3,000 participants

Structured Rehabilitation & Pacing

Used for 1 condition

1 trials · 3,000 participants

Methyldopa

Used for 1 condition

100 trials · 3,000 participants

Bevacizumab + Pemetrexed + Cisplatin

Used for 1 condition

3 trials · 3,000 participants

Non-Invasive Ventilation (NIV)

Used for 1 condition

39 trials · 3,000 participants

FOLFIRINOX (Folinic acid, Fluorouracil, Irinotecan, Oxaliplatin)

Used for 1 condition

100 trials · 3,000 participants

Gabapentin Enacarbil

Used for 1 condition

26 trials · 3,000 participants

Intra-arterial Chemotherapy (IAC)

Used for 1 condition

2 trials · 3,000 participants

Tranexamic Acid (TXA)

Used for 1 condition

1 trials · 3,000 participants

Elagolix + Estradiol/Norethindrone Acetate

Used for 1 condition

9 trials · 3,000 participants

Bupropion Sustained Release

Used for 1 condition

22 trials · 2,600 participants

Dimethyl Fumarate

Used for 1 condition

103 trials · 2,600 participants

Verapamil

Used for 1 condition

3 trials · 2,500 participants

Delamanid (as part of longer regimens)

Used for 1 condition

15 trials · 2,500 participants

Gemifloxacin + Azithromycin (Dual Therapy, Oral Alternative)

Used for 1 condition

18 trials · 2,500 participants

Pirfenidone

Used for 1 condition

1 trials · 2,500 participants

Physical and Occupational Therapy

Used for 1 condition

1 trials · 2,500 participants

Gastrostomy (PEG Tube)

Used for 1 condition

5 trials · 2,500 participants

Gemcitabine + Nab-paclitaxel

Used for 1 condition

396 trials · 2,500 participants

Riociguat

Used for 1 condition

47 trials · 2,500 participants

Intravitreal Chemotherapy (IViC)

Used for 1 condition

40 trials · 2,500 participants

Transcranial Magnetic Stimulation (TMS)

Used for 1 condition

35 trials · 2,500 participants

Honey

Used for 1 condition

8 trials · 2,500 participants

Combination Therapies (e.g., Liposomal Amphotericin B + Miltefosine)

Used for 1 condition

25 trials · 2,500 participants

Pimavanserin

Used for 1 condition

2 trials · 2,200 participants

Sertraline

Used for 2 conditions

35 trials · 2,100 participants

Tisagenlecleucel (CAR T-cell Therapy)

Used for 1 condition

6 trials · 2,000 participants

Venetoclax + Azacitidine

Used for 1 condition

253 trials · 2,000 participants

NECT (Nifurtimox-Eflornithine Combination Therapy)

Used for 1 condition

2 trials · 2,000 participants

Enfortumab Vedotin (Padcev)

Used for 1 condition

19 trials · 2,000 participants

Larazotide Acetate (Investigational)

Used for 1 condition

10 trials · 2,000 participants

Ketoconazole

Used for 1 condition

4 trials · 2,000 participants

Plasma Exchange (PLEX)

Used for 1 condition

70 trials · 2,000 participants

Pegloticase

Used for 1 condition

18 trials · 2,000 participants

Bedaquiline + Pretomanid + Linezolid (BPaL Regimen)

Used for 1 condition

12 trials · 2,000 participants

Mavacamten

Used for 1 condition

31 trials · 2,000 participants

Disopyramide

Used for 1 condition

4 trials · 2,000 participants

Dimethyl Sulfoxide (DMSO)

Used for 1 condition

5 trials · 2,000 participants

Mifamurtide (Adjuvant for High-Grade Osteosarcoma, non-US approval)

Used for 1 condition

15 trials · 2,000 participants

Hydralazine (IV)

Used for 1 condition

50 trials · 2,000 participants

Endolymphatic Sac Decompression

Used for 1 condition

25 trials · 2,000 participants

Riluzole

Used for 1 condition

43 trials · 2,000 participants

Natalizumab

Used for 1 condition

126 trials · 2,000 participants

Glatiramer Acetate

Used for 1 condition

108 trials · 2,000 participants

Cemiplimab

Used for 1 condition

7 trials · 2,000 participants

Vitamin B6

Used for 1 condition

4 trials · 2,000 participants

Rotigotine

Used for 1 condition

23 trials · 2,000 participants

Brimonidine (topical)

Used for 1 condition

9 trials · 2,000 participants

Systemic Corticosteroid Pulse Therapy (e.g., Dexamethasone)

Used for 1 condition

30 trials · 2,000 participants

Cladribine

Used for 1 condition

42 trials · 1,900 participants

Varenicline solution (nasal spray)

Used for 1 condition

4 trials · 1,800 participants

Methylphenidate Extended-Release

Used for 1 condition

18 trials · 1,600 participants

Pegylated Interferon-alpha

Used for 1 condition

30 trials · 1,500 participants

Midostaurin + Chemotherapy

Used for 1 condition

23 trials · 1,500 participants

Specialist Supportive Clinical Management (SSCM)

Used for 1 condition

10 trials · 1,500 participants

Latiglutenase (ALV003 / BL-7010) (Investigational)

Used for 1 condition

8 trials · 1,500 participants

Modafinil

Used for 1 condition

25 trials · 1,500 participants

Ethionamide / Prothionamide (as part of regimens)

Used for 1 condition

20 trials · 1,500 participants

Cycloserine / Terizidone (as part of regimens)

Used for 1 condition

20 trials · 1,500 participants

Myo-inositol + Selenium

Used for 1 condition

1 trials · 1,500 participants

Bedaquiline + Pretomanid + Linezolid + Moxifloxacin (BPaLM Regimen)

Used for 1 condition

15 trials · 1,500 participants

Delamanid + Bedaquiline + Optimized Background Regimen (OBR)

Used for 1 condition

15 trials · 1,500 participants

BPaL Regimen (Bedaquiline, Pretomanid, Linezolid)

Used for 1 condition

15 trials · 1,500 participants

Watchful Waiting (for Asymptomatic Inguinal Hernia in Men)

Used for 1 condition

7 trials · 1,500 participants

Heparin/Lidocaine (intravesical)

Used for 1 condition

8 trials · 1,500 participants

Sunitinib

Used for 1 condition

241 trials · 1,500 participants

Pazopanib

Used for 1 condition

100 trials · 1,500 participants

Cognitive Rehabilitation Therapy

Used for 1 condition

29 trials · 1,500 participants

Oxybutynin (low-dose extended release)

Used for 1 condition

8 trials · 1,500 participants

Alemtuzumab

Used for 1 condition

46 trials · 1,500 participants

Brachytherapy (Plaque Radiotherapy)

Used for 1 condition

3 trials · 1,500 participants

Oxymetazoline (topical)

Used for 1 condition

2 trials · 1,500 participants

Voxelotor

Used for 1 condition

25 trials · 1,500 participants

Paromomycin

Used for 1 condition

11 trials · 1,500 participants

Galcanezumab

Used for 1 condition

3 trials · 1,200 participants

Tailored Exercise Rehabilitation with Pacing

Used for 1 condition

12 trials · 1,200 participants

Voclosporin

Used for 1 condition

10 trials · 1,200 participants

Talimogene laherparepvec (T-VEC)

Used for 1 condition

4 trials · 1,200 participants

Ruxolitinib Cream (Opzelura)

Used for 1 condition

1 trials · 1,200 participants

CPX-351 (Liposomal Cytarabine and Daunorubicin)

Used for 1 condition

43 trials · 1,000 participants

Letrozole

Used for 1 condition

6 trials · 1,000 participants

BPaL regimen (Bedaquiline + Pretomanid + Linezolid)

Used for 1 condition

1 trials · 1,000 participants

Clofazimine (as part of regimens)

Used for 1 condition

15 trials · 1,000 participants

Hydroxyzine

Used for 1 condition

20 trials · 1,000 participants

Minimally Invasive Surgery (Stereotactic Aspiration/Endoscopic) + rt-PA

Used for 1 condition

1 trials · 1,000 participants

Immunotherapy (PD-1 Inhibitors e.g., Pembrolizumab/Nivolumab)

Used for 1 condition

20 trials · 1,000 participants

Idecabtagene vicleucel (ide-cel)

Used for 1 condition

28 trials · 1,000 participants

Fetal Myelomeningocele Repair (Maternal-Fetal Surgery)

Used for 1 condition

4 trials · 1,000 participants

Prednisone (Oral)

Used for 1 condition

50 trials · 1,000 participants

Surgical Debridement

Used for 1 condition

10 trials · 1,000 participants

Intranasal Cobalamin (Cyanocobalamin)

Used for 1 condition

20 trials · 1,000 participants

Adolescent-Focused Psychotherapy (AFP)

Used for 1 condition

5 trials · 800 participants

High-flow Oxygen

Used for 1 condition

1 trials · 800 participants

Neostigmine (for Acute Colonic Pseudo-obstruction)

Used for 1 condition

15 trials · 800 participants

Naltrexone (low-dose)

Used for 1 condition

3 trials · 750 participants

Naltrexone (Low-Dose)

Used for 1 condition

3 trials · 750 participants

Crizanlizumab

Used for 1 condition

15 trials · 750 participants

Gilteritinib

Used for 1 condition

58 trials · 700 participants

Fexinidazole

Used for 1 condition

10 trials · 700 participants

ZED1227 (Investigational)

Used for 1 condition

5 trials · 700 participants

Luspatercept (Reblozyl)

Used for 1 condition

4 trials · 700 participants

Bedaquiline-Pretomanid-Linezolid (BPaL) Regimen

Used for 1 condition

8 trials · 650 participants

Zolmitriptan (nasal spray)

Used for 1 condition

12 trials · 600 participants

Edaravone

Used for 1 condition

11 trials · 600 participants

Entecavir

Used for 1 condition

4 trials · 500 participants

Tenofovir disoproxil fumarate (TDF)

Used for 1 condition

3 trials · 500 participants

Mifepristone

Used for 1 condition

10 trials · 500 participants

Pasireotide

Used for 1 condition

5 trials · 500 participants

Citalopram

Used for 1 condition

1 trials · 500 participants

Pemigatinib (FGFR2 Inhibitor)

Used for 1 condition

30 trials · 500 participants

Cabozantinib

Used for 1 condition

95 trials · 500 participants

Azathioprine (Immunosuppressant)

Used for 1 condition

2 trials · 500 participants

Olaparib (PARP inhibitor)

Used for 1 condition

20 trials · 500 participants

Cyclosporine (Oral)

Used for 1 condition

20 trials · 500 participants

Tenofovir alafenamide (TAF)

Used for 1 condition

2 trials · 400 participants

Osilodrostat

Used for 1 condition

9 trials · 400 participants

Paroxetine

Used for 1 condition

15 trials · 400 participants

L-Glutamine (Endari)

Used for 1 condition

7 trials · 400 participants

Pembrolizumab + Lenvatinib

Used for 1 condition

26 trials · 355 participants

Magnesium supplements

Used for 1 condition

7 trials · 350 participants

H1 and H2 Antihistamines (e.g., Fexofenadine, Famotidine)

Used for 1 condition

8 trials · 350 participants

Trazodone

Used for 1 condition

10 trials · 300 participants

Ivosidenib (IDH1 Inhibitor)

Used for 1 condition

20 trials · 300 participants

Topical Corticosteroids (e.g., Clobetasol) / Topical Tacrolimus

Used for 1 condition

15 trials · 300 participants

Betibeglogene Autotemcel (Beti-cel / Zynteglo)

Used for 1 condition

5 trials · 300 participants

Papaverine (Intra-arterial)

Used for 1 condition

30 trials · 300 participants

Tofersen (for SOD1-ALS)

Used for 1 condition

1 trials · 200 participants

Exagamglogene autotemcel (Casgevy)

Used for 1 condition

7 trials · 150 participants

Whole Lung Lavage

Used for 1 condition

1 trials · 90 participants

Anti-fibrotic agents (e.g., Pirfenidone, Nintedanib)

Used for 1 condition

4 trials · 80 participants

Supportive Care (Rest, Hydration, Nutrition)

Used for 1 condition

0 trials · 0 participants

Gluten-Free Diet (GFD)

Used for 1 condition

21 trials · 0 participants

Avoidance of Oxidative Stressors (e.g., Fava Beans, Sulfa Drugs, Antimalarials)

Used for 1 condition

0 trials · 0 participants

Blood Transfusion (for acute severe hemolysis)

Used for 1 condition

0 trials · 0 participants

Supportive Care (Fluid Management, Antipyretics, Nutritional Support)

Used for 1 condition

0 trials · 0 participants

Enucleation

Used for 1 condition

10 trials · 0 participants

Focal Therapies (Laser Photocoagulation, Transpupillary Thermotherapy, Cryotherapy)

Used for 1 condition

0 trials · 0 participants

Supportive Care (IV Fluids, Bowel Rest)

Used for 1 condition

0 trials · 0 participants

Rest and Hydration

Used for 1 condition

0 trials · 0 participants
Treatments | Optimitron